Navigation Links
ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria
Date:7/24/2014

BURLINGAME, Calif., July 24, 2014 /PRNewswire/ -- ECC West Africa, LLC (ECC) signed a contract in Denver, Colorado with University College Hospital (UCH) Ibadan Board of Management for the first phase of a development project to finance, design, construct, and operate and maintain a new, state-of-the-art Cancer Institute in Ibadan, Nigeria. Under the first of the 4-phase project, ECC will conduct feasibility studies and prepare scoping documents and funding applications. UCH Ibadan intends to finance and develop the Cancer Institute using funding from Export-Import Bank and other financial institutions.

The Cancer Institute will be an innovative, holistic diagnostic center, including oncological screening, diagnosis, treatment, prevention, training, and research.

"Medical infrastructure and accessibility are critical steps in leading the fight against disease throughout Africa," comments ECC's President & CEO, Manjiv S. Vohra, PE, DBIA.  "UCH Ibadan and its new Cancer Institute will provide premier oncological services, touching the lives of millions of people and their families affected by cancer. We are proud to lead the development of this ground-breaking institution."

Professor Temitope Oluwagbenga Alonge, MBBS Ibadan, MD Leicester, FRCS Edinburgh, FWACS, UCH Ibadan Chief Medical Director, represented the Board of Management during the signing. He stated, "Cancer is a leading cause of death at UCH Ibadan. Accurate diagnosis of cancer is germane to targeted treatment modalities. Our partnership with ECC, a world-class, renowned, and reputable company, will no doubt ensure a more accurate diagnosis, and by extension, appropriate and targeted treatment of cancers, as well as offer opportunities for cutting-edge research and the development of protocols in UCH, Nigeria, and the West African sub-region."

ECC teamed with strategic partners General Electric Healthcare and Health Technologies International to develop the Cancer Institute. Additionally, a major component of the project involves building capacity of the local workforce. "ECC invests heavily in building relationships with local Nigerian partners who will play a pivotal role in the development of the Cancer Institute," stated Mr. Vohra.

The UCH Ibadan Cancer Institute is estimated to be completed within 2 years.

About UCH Ibadan: Established by an act of parliament in November 1952, UCH Ibadan is the leading teaching hospital and tertiary healthcare provider in Nigeria. UCH Ibadan provides excellent healthcare training, cutting-edge research, and unparalleled healthcare services to Nigerians and citizens of neighboring West African States. Its Accident and Emergency Department averages 6,000 new patients annually, and its clinics serve 150,000 new patients each year. uch-ibadan.org.ng

About ECC: Established in 1985, ECC is an employee-owned company that provides a complete range of services to support its clients' missions, including design-build, construction, environmental remediation, energy, munitions response, and international development. ECC serves the U.S. Agency for International Development; U.S. Departments of Defense, Energy, and State; and other international agencies.  www.ecc.net


'/>"/>
SOURCE ECC
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Bacterin Signs Distribution Agreement with Jeil for LeForte Craniomaxillofacial System
2. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
3. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
4. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
5. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
6. Agendia Signs Contract with Blue Shield of California
7. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
8. Volition Signs Collaboration Agreement With Abcodia
9. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
10. Psyche Systems Corporation Signs Strategic Alliance with Siemens Healthcare to Provide Anatomic Pathology Solutions
11. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... ... a different cell type. Many treatments for specific cancers, such as breast, prostate, ... targeted treatment is androgen deprivation therapy for advanced prostate cancer. , This ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... third U.S. Food and Drug Administration (FDA) inspection at our Dilworth, MN site. ... 483 was issued. This inspection was conducted as part of a routine Bioresearch ...
(Date:8/15/2017)... -- After spending the past two years building a state-of-the-art technology ... now offers this platform to healthcare stakeholders (hospitals, foundations, biopharma companies ... data collection vis a vis their members, under their own brand. ... this offer. ... ...
(Date:8/15/2017)... ... August 15, 2017 , ... ... largest Asian exhibitions for analytical and scientific instruments. This year’s symposium, organized by ... Approaches in Mass Spectrometry for Bioanalytical Applications.” This dynamic presentation will discuss novel ...
Breaking Biology Technology:
(Date:5/6/2017)... RAM Group , Singaporean based ... in biometric authentication based on a novel  ... to perform biometric authentication. These new sensors are based on ... Ram Group and its partners. This sensor will have ... and security. Ram Group is a next generation ...
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced Design ... will feature emerging and evolving technology through its ... Summits will run alongside the expo portion of the ... panels and demonstrations focused on trending topics within 3D ... design and manufacturing event will take place June 13-15, 2017 ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
Breaking Biology News(10 mins):